AUTHOR=Ma Wei , Zhao Zhengde , Fu Qining , Hu Liangzhu , Zhao Xia , Wang Chao , Liu Yangdong 

TITLE=Comparison of Management for Central Venous Stenosis With or Without Previous Catheter Placement

JOURNAL=Frontiers in Neurology

VOLUME=Volume 12 - 2021

YEAR=2021

URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.703286

DOI=10.3389/fneur.2021.703286

ISSN=1664-2295

ABSTRACT=Objective: To compare central venous stenosis/occlusion with or without previous jugular catheter placement history.
Methods: Data of patients with central vein stenosis/occlusion receiving endovascular intervention in our hospital from January 2015 to December 2018 were collected and analyzed. 
Results: 29 patients with previous jugular catheter placement history (CVC group) and 33 patients (excluded 2 with technical failure) without such history (non-CVC group) included in this study. Previous jugular catheter placement history rose the risk of recurrence for 1.02 times (CVC group v.s. non-CVC group, HR=2.02 95%CI: 0.91-4.48). The primary patency rate at 6, 12, 18 and 24 months was 76.9%, 54.2%, 45.5% and 25.0% separately in CVC group, and 80.6%, 70.0%, 67.9% and 44.4% separately in non-CVC group. The assisted primary patency rate at 6, 12, 18 and 24 months was 92.3%, 91.7%, 86.4% and 68.8% separately in CVC group, and 93.5%, 90.0%, 82.1% and 61.1% separately in non-CVC group. Patients in CVC group received a higher frequency of re-intervention (0.7 times/year/patient v.s. 0.3 times/year/patient). There was no significant difference in the assisted primary patency rate between two groups. Different primary interventions (angioplasty alone, bare metal stent, stent graft) didn’t affect primary patency and assisted primary patency, but percutaneous transluminal stenting (PTS) with bare metal stent had a significant lower primary patency rate between 3-24 months comparing with PTS with stent graft (p=0.011).
Conclusion: Central venous stenosis/occlusion with previous jugular catheter placement history develops symptoms earlier and had a worse prognosis after endovascular intervention. More efforts are needed to carry out end-stage kidney disease “Life-Plan” to reduce the harm of evitable catheter placement.